Bharat Immunologicals & Biologicals Corporation Ltd (BIBCL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Bharat Immunologicals & Biologicals Corporation Ltd on NSE and BSE, with an AI summary of each filing.
The Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on September 30, 2026 with reference to significant movement in price, in order to ensure ....
Others (Uncategorized) · 30 Sept 2026, 11:45 pm
Pursuant to the Regulation 30 and other applicable Regulation(s) of SEBI LODR, It is informed that the Government of India has approved the closure of Bharat Immunologicals and Biologicals ....
Others (Uncategorized) · 17 Sept 2026, 5:14 pm
Government of India Approves Closure of BIBCOL The Government of India has approved the closure of Bharat Immunologicals & Biologicals Corporation Limited (BIBCOL), operating under the administrative control of the Department of Biotechnology, Ministry of Science and Technology. The company disclosed this regulatory development pursuant to Regulation 30 of SEBI LODR Regulations following official communication received from the Department of Biotechnology on 17th Sep'26.
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 ,inter alia, to consider and approve ....
Intimation · 07 Aug 2024, 10:28 pm
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 ,inter alia, to consider and approve ....
Intimation · 29 Feb 2024, 10:27 pm
Submission of Draft Annual Report 2022-23 for AGM on 29.12.2023
Annual General Meeting · 13 Dec 2023, 9:13 pm
Intimation of Book Closure in respect of AGM
Annual General Meeting · 28 Nov 2023, 7:40 pm
Annual General Meeting of Shareholders for the year 2022-23 is scheduled to be held on 29.12.2023. Submitted for kind information and record please.
Annual General Meeting · 28 Nov 2023, 7:23 pm
Submission of UAFR alongwith Limited Review Report for the quarter and half year ended September 2023
Financial Result · 01 Nov 2023, 11:28 pm
submission of UAFR June 2023<BR>
Financial Result · 01 Nov 2023, 11:22 pm
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 ,inter alia, to consider and approve ....
Intimation · 31 Oct 2023, 5:30 am
As captioned subject
Others (Uncategorized) · 15 Sept 2023, 9:19 pm
The Annual Accounts i.e. the Balance Sheet and Statement of Profit & Loss account approved by Board in its meeting held on 24.04.2023 and provided to Statutory Auditors for the year ended ....
Financial Result · 31 May 2023, 8:22 pm
The Board Meeting to be held on 24/04/2023 has been revised to 24/04/2023 The Board Meeting to be held on 24/04/2023 has been revised to 24/04/2023
Intimation · 24 Apr 2023, 5:30 am
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2023 ,inter alia, to consider and approve ....
Intimation · 24 Apr 2023, 5:30 am
In compliance of SEBI LODR with Stock Exchange, please find enclosed the Unaudited Quarterly Financial Results for the quarter and nine months ended December 2022 along with Limited Review ....
Financial Result · 10 Feb 2023, 6:05 pm
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve ....
Intimation · 09 Feb 2023, 5:30 am
The Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on December 27, 2022, with reference to Movement in Price.<BR><BR>The reply is awaited.
Others (Uncategorized) · 27 Dec 2022, 6:37 pm
In pursuance of the SEBI LODR, please find attached the Un-audited Quarterly Financial Results for the quarter ended September 2022 and Limited Review Report thereon as per the Compliance of LODR 2015
Financial Result · 17 Oct 2022, 11:06 pm
<table border=''1''><tr bgcolor=''#d6d6d6''><th class=''TTRow_left''> No.of Investor complaints pending at the beginning of the quarter </th><th class=''TTRow''> No.of Investor complaints received during the quarter</th><th class=''TTRow''> No.of Investor complaints disposed of during the quarter </th><th class=''TTRow''> No.of Investor complaints unresolved at the end of the quarter </th></tr><tr><td class=''TTRow''>0</td><td class=''TTRow''>0</td><td class=''TTRow''>0</td><td class=''TTRow''>0</td></tr></table><table border=''1''><tr><td > <span style=''font-weight:bold''>Name of the Signatory </span> </td><td> :- </td><td>SANDIP KUMAR LAL</td></tr><tr><td ><span style=''font-weight:bold''>Designation </span></td><td> :- </td><td>Company Secretary and Compliance Officer</td></tr></table>
Others (Uncategorized) · 11 Oct 2022, 5:57 pm
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2022 ,inter alia, to consider and approve ....
Intimation · 17 Oct 2022, 5:30 am
The Annual General Meeting of the Shareholder of the company is scheduled on 30.09.2022, and the Annual Report to be placed at Shareholders meeting for consideration is submitted at BSE please.
Annual Report · 23 Sept 2022, 10:51 pm
In pursuance of the provision of LODR 2015, please find attached herewith the Notice of 33rd Annual General Meeting of the Company on 30.09.2022 for the financial year 2021-22. The Notice ....
Annual General Meeting · 06 Sept 2022, 9:52 pm
In pursuance of the SEBI LODR, please find attached the Un-audited Quarterly Financial Results for the quarter ended June 2022 and Limited Review Report thereon as per the Compliance of LODR 2015.
Financial Result · 15 Aug 2022, 4:18 pm
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 ,inter alia, to consider and approve ....
Intimation · 11 Aug 2022, 5:30 am
In compliance of SEBI LODR with Stock Exchange, please find enclosed the Reviewed Annual Financial Results for the year ended 31st March 2022.<BR>
Financial Result · 31 May 2022, 10:54 pm